WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth

Developmental Dynamics

Volumn 237, Issue 4, 2008, Pages 1006-1020

  Potok, Mary Anne ^a   Cha, Kelly B ^a   Hunt, Andrea ^a   Brinkmeier, Michelle L ^a   Leitges, Michael ^b   Kispert, Andreas ^c   Camper, Sally A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Development; Mouse knockout; Wnt11; Wnt16; Wnt4; Wnt5a; Wnt6

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MUTANT PROTEIN; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR PIT 1; WNT PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; DIENCEPHALON; EMBRYO; GENE EXPRESSION; HYPOPHYSIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINEAGE; DIENCEPHALON; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOGENESIS; MUTATION; PHENOTYPE; PITUITARY GLAND; PITUITARY HORMONES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

MUS;

EID: 42149180590     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21511     Document Type: Article

References (58)

1. Asbreuk CH, van Doorninck JH, Mansouri A, Smidt MP, Burbach JP. 2006. Neurohypophysial dysmorphogenesis in mice lacking the homeobox gene Uncx4.1. J Mol Endocrinol 36:65-71.
2. Brinkmeier ML, Potok MA, Cha KB, Gridley T, Stifani S, Meeldijk J, Clevers H, Camper SA. 2003. TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol 17:2152-2161.
3. Brinkmeier ML, Potok MA, Davis SW, Camper SA. 2007. TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol 311:396-407.
4. Cadigan KM, Nusse R. 1997. Wnt signaling: a common theme in animal development. Genes Dev 11:3286-3305.
5. Camper SA. 2004. Sox3 and sexual dysfunction: it's in the head. Nat Genet 36:217-219.
6. Camper SA, Saunders TL, Katz RW, Reeves RH. 1990. The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics 8:586-590.
7. Carninci P, Waki K, Shiraki T, Konno H, Shibata K, Itoh M, Aizawa K, Arakawa T, Ishii Y, Sasaki D, Bono H, Kondo S, Sugahara Y, Saito R, Osato N, Fukuda S, Sato K, Watahiki A, Hirozane-Kishikawa T, Nakamura M, Shibata Y, Yasunishi A, Kikuchi N, Yoshiki A, Kusakabe M, Gustincich S, Beisel K, Pavan W, Aidinis V, Nakagawara A, Held WA, Iwata H, Kono T, Nakauchi H, Lyons P, Wells C, Hume DA, Fagiolini M, Hensch TK, Brinkmeier M, Camper S, Hirota J, Mombaerts P, Muramatsu M, Okazaki Y, Kawai J, Hayashizaki Y. 2003. Targeting a complex transcriptome: the construction of the mouse full-length cDNA encyclopedia. Genome Res 13:1273-1289.
8. Cha KB, Douglas KR, Potok MA, Liang H, Jones SN, Camper SA. 2004. WNT5A signaling affects pituitary gland shape. Mech Dev 121:183-194.
9. Charles MA, Suh H, Hjalt TA, Drouin J, Camper SA, Gage PJ. 2005. PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol 19:1893-1903.
10. Cushman LJ, Camper SA. 2001. Molecular basis of pituitary dysfunction in mouse and human. Mamm Genome 12:485-494.
11. Dasen JS, Barbera JP, Herman TS, Connell SO, Olson L, Ju B, Tollkuhn J, Baek SH, Rose DW, Rosenfeld MG. 2001. Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 15:3193-3207.
12. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC. 1998. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125-133.
13. Davis SW, Camper SA. 2007. Noggin regulates Bmp4 activity during pituitary induction. Dev Biol 305:145-160.
14. Douglas KR, Brinkmeier ML, Kennell JA, Eswara P, Harrison TA, Patrianakos AI, Sprecher BS, Potok MA, Lyons RH Jr, MacDougald OA, Camper SA. 2001. Identification of members of the Wnt signaling pathway in the embryonic pituitary gland. Mamm Genome 12:843-851.
15. Ericson J, Norlin S, Jessell TM, Edlund T. 1998. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 125:1005-1015.
16. Ellsworth BS, Egashira N, Haller JL, Butts DL, Cocquet J, Clay CM, Osamura RY, Camper SA. 2006. FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 20:2796-2805.
17. Ellsworth BS, Butts DL, Camper SA. 2008. Mechanisms underlying pituitary hypoplasia and failed cell specification in Lhx3-deficient mice. Dev Biol 313:118-129.
18. Gardner S, Maudsley S, Millar RP, Pawson AJ. 2007. Nuclear stabilization of {beta}-catenin and inactivation of glycogen synthase kinase-3{beta} by gonadotropin-releasing hormone: targeting Wnt signaling in the pituitary gonadotrope. Mol Endocrinol 21:3028-3038.
19. Gummow BM, Winnay JN, Hammer GD. 2003. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J Biol Chem 278:26572-26579.
20. Guo X, Day TF, Jiang X, Garrett-Beal L, Topol L, Yang Y. 2004. Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev 18:2404-2417.
21. Heller RS, Dichmann DS, Jensen J, Miller C, Wong G, Madsen OD, Serup P. 2002. Expression patterns of Wnts, Frizzleds, sFRPs, and misexpression in transgenic mice suggesting a role for Wnts in pancreas and foregut pattern formation. Dev Dyn 225:260-270.
22. Howng SL, Wu CH, Cheng TS, Sy WD, Lin PC, Wang C, Hong YR. 2002. Differential expression of Wnt genes, beta-catenin and E-Cadherin in human brain tumors. Cancer Lett 183:95-101.
23. Ikeda H, Yoshimoto T. 1991. Developmental changes in proliferative activity of cells of the murine Rathke's pouch. Cell Tissue Res 263:41-47.
24. Japon MA, Rubinstein M, Low MJ. 1994. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 42:1117-1125.
25. Kendall SK, Gordon DF, Birkmeier TS, Petrey D, Sarapura VD, O'Shea KS, Wood WM, Lloyd RV, Ridgway EC, Camper SA. 1994. Enhancer-mediated high level expression of mouse pituitary glycoprotein hormone alpha-subunit transgene in thyrotropes, gonadotropes, and developing pituitary gland. Mol Endocrinol 8:1420-1433.
26. Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, Brault V, Ruiz-Lozano P, Nguyen HD, Kemler R, Glass CK, Wynshaw-Boris A, Rosenfeld MG. 2002. Identification of a Wnt/Dvl/beta-Catenin → Pitx2 pathway mediating cell-type-specific proliferation during development. Cell 111:673-685.
27. Kohn AD, Moon RT. 2005. Wnt and calcium signaling: beta-catenin- independent pathways. Cell Calcium 38:439-446.
28. Kuhl M, Sheldahl LC, Park M, Miller JR, Moon RT. 2000. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16:279-283.
29. Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. 1990. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-533.
30. Li C, Xiao J, Hormi K, Borok Z, Minoo P. 2002. Wnt5a participates in distal lung morphogenesis. Dev Biol 248:68-81.
31. Li C, Hu L, Xiao J, Chen H, Li JT, Bellusci S, Delanghe S, Minoo P. 2005. Wnt5a regulates Shh and Fgf10 signaling during lung development. Dev Biol 287:86-97.
32. Majumdar A, Vainio S, Kispert A, McMahon J, McMahon AP. 2003. Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development. Development 130:3175-3185.
33. Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, Hassan AB, Volpin D, Bressan GM, Piccolo S. 2003. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 100:3299-3304.
34. Meynen G, Unmehopa UA, Hofman MA, Swaab DF, Hoogendijk WJ. 2007. Relation between corticotropin-releasing hormone neuron number in the hypothalamic paraventricular nucleus and depressive state in Alzheimer's disease. Neuroendocrinology 85:37-44.
35. Mikels AJ, Nusse R. 2006. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115.
36. Mitchell PJ, Hanson JC, Quets-Nguyen AT, Bergeron M, Smith RC. 2007. A quantitative method for analysis of in vitro neurite outgrowth. J Neurosci Methods 164:350-362.
37. Myers DC, Sepich DS, Solnica-Krezel L. 2002. Bmp activity gradient regulates convergent extension during zebrafish gastrulation. Dev Biol 243:81-98.
38. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, Rose D, Li X, Rosenfeld MG. 2006. Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 125:593-605.
39. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E. 2003. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci U S A 100:1034-1039.
40. Raetzman LT, Ward R, Camper SA. 2002. Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 129:4229-4239.
41. Raetzman LT, Cai JX, Camper SA. 2007. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 304:455-466.
42. Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R. 1987. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 50:649-657.
43. Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, Lovell-Badge R. 2004. SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 36:247-255.
44. Rizzoti K, Lovell-Badge R. 2005. Early development of the pituitary gland: induction and shaping of Rathke's pouch. Rev Endocr Metab Disord 6:161-172.
45. Shimogori T, Banuchi V, Ng HY, Strauss JB, Grove EA. 2004. Embryonic signaling centers expressing BMP, WNT and FGF proteins interact to pattern the cerebral cortex. Development 131:5639-5647.
46. Solomon NM, Ross SA, Morgan T, Belsky JL, Hol FA, Karnes PS, Hopwood NJ, Myers SE, Tan AS, Warne GL, Forrest SM, Thomas PQ. 2004. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 41:669-678.
47. Stark K, Vainio S, Vassileva G, McMahon AP. 1994. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372:679-683.
48. Takuma N, Sheng HZ, Furuta Y, Ward JM, Sharma K, Hogan BL, Pfaff SL, Westphal H, Kimura S, Mahon KA. 1998. Formation of Rathke's pouch requires dual induction from the diencephalon. Development 125:4835-4840.
49. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899-908.
50. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG. 1998. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12:1691-1704.
51. Wang J, Shackleford GM. 1996. Murine Wnt10a and Wnt10b: cloning and expression in developing limbs, face and skin of embryos and in adults. Oncogene 13:1537-1544.
52. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA. 2005. Role of PROP1 in pituitary gland growth. Mol Endocrinol 19:698-710.
53. Ward RD, Stone BM, Raetzman LT, Camper SA. 2006. Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 20:1378-1390.
54. Watkins-Chow DE, Camper SA. 1998. How many homeobox genes does it take to make a pituitary gland? Trends Genet 14:284-290.
55. Yamaguchi TP, Bradley A, McMahon AP, Jones S. 1999. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126:1211-1223.
56. Yanagita M, Okuda T, Endo S, Tanaka M, Takahashi K, Sugiyama F, Kunita S, Takahashi S, Fukatsu A, Yanagisawa M, Kita T, Sakurai T. 2006. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 116:70-79.
57. Zhao Y, Morales DC, Hermesz E, Lee WK, Pfaff SL, Westphal H. 2006. Reduced expression of the LIM-homeobox gene Lhx3 impairs growth and differentiation of Rathke's pouch and increases cell apoptosis during mouse pituitary development. Mech Dev 123:605-613.
58. Zhou W, Lin L, Majumdar A, Li X, Zhang X, Liu W, Etheridge L, Shi Y, Martin J, Van de Ven W, Kaartinen V, Wynshaw-Boris A, McMahon AP, Rosenfeld MG, Evans SM. 2007. Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGFbeta2. Nat Genet 39:1225-1234.